A schematic of the typical drug supply chain structure, from suppliers to a treatment center, which may not hold for all countries

FIGURE 8-1A schematic of the typical drug supply chain structure, which may not hold for all countries

Challenges in the supply chain for MDR TB drugs extend from grant disbursement to distribution.

NOTE: DOTS = Directly Observed Treatment-Short course; MIS = management information systems; MoH = Ministry of Health.

SOURCE: Yadav, 2011.

From: 8, Confronting Challenges to the Supply Chain for Second-Line Drugs

Cover of Facing the Reality of Drug-Resistant Tuberculosis in India
Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research.
Institute of Medicine (US).
Washington (DC): National Academies Press (US); 2012.
Copyright © 2012, National Academy of Sciences.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.